Rising Costs of Medicare Advantage Plans: A $76 Billion Dilemma
Medicare Advantage plans are reportedly receiving overpayments amounting to approximately $76 billion annually due to discrepancies in diagnosis coding. This results in an additional $212 being included in the 2025 Medicare Part B premiums for beneficiaries without detailed itemization, accumulating to $82 billion in excess payments since 2016.
According to the Medicare Payment Advisory Commission (MedPAC), the costs per person for Medicare Advantage exceed those of traditional Medicare by 20%. Furthermore, the Joint Economic Committee anticipates that a substantial portion, approximately $450, of the predicted annual Part B premium increases over the next decade will derive from these overpayments to private insurers.
An analysis by the Congressional Joint Economic Committee indicates that these excess payments create additional costs for all beneficiaries, reflected in their premiums rather than as separate charges. The operational mechanism involves private insurers receiving payments based on documented diagnoses, potentially inflating costs by portraying members as having more severe health conditions than what might be accurate. This practice increases Medicare Advantage costs compared to traditional Medicare, affecting Part B premiums across the board, irrespective of beneficiaries' plan choices.
As of projections, it is estimated that since 2016, Medicare Advantage overcharges have added $82 billion to Part B premiums, with those under traditional Medicare shouldering about $6 billion of this increase. Looking ahead, the Joint Economic Committee estimates that Medicare Advantage plans will be overpaid by another $76 billion in 2026. Should the current trend persist, these extra payments might total $1.2 trillion over the subsequent decade.
Projections suggest that average Part B premiums per person could nearly double in the next ten years, escalating from $2,440 to around $5,000 annually. This increase poses challenges for households, particularly those on fixed incomes. In addition, health expenditure nationally has seen significant growth, with personal healthcare consumption reaching $3.74 trillion in early 2026.
Various healthcare trade groups contest the analysis, arguing that the purported overpayments do not account for savings and improved outcomes achieved through Medicare Advantage plans' care coordination and additional benefits. Notably, MedPAC, a nonpartisan advisory body, has consistently documented these cost discrepancies for several years.
Currently, Medicare Advantage covers more than half of Medicare beneficiaries. The original intent of the program, introduced in the late 1990s, was cost savings through a fixed payment model to private insurers. However, subsequent reports, such as that from the Joint Economic Committee, highlight significant deviations from these anticipated savings.